- Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
- Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
- Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
- Infectious diarrhea is the most common illness reported by travelers
Deutsche Bank Downgrades Ford Motor to Sell, Announces $11 Price Target
Deutsche Bank analyst Emmanuel Rosner downgrades Ford Motor (NYSE:F) from Hold to Sell and announces $11 price target.